Aspirin and P2Y12 inhibitors in treating COVID-19

被引:2
|
作者
Khalaji, Amirmohammad [1 ]
Behnoush, Amir Hossein [1 ]
Peiman, Soheil [2 ,3 ]
机构
[1] Univ Tehran Med Sci, Sch Med, Tehran, Iran
[2] AdventHlth Orlando Hosp, Dept Internal Med, Orlando, FL USA
[3] AdventHlth Orlando Hosp, Dept Internal Med, 601 E Rollins St Suite 400, Orlando, FL 32803 USA
关键词
COVID-19; Aspirin; P2Y12; inhibitors; Platelet aggregation inhibitors; Meta-analysis;
D O I
10.1016/j.ejim.2022.11.027
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:101 / 103
页数:3
相关论文
共 50 条
  • [1] P2y12 Inhibitors in Noncritically Ill Hospitalized Patients With Covid-19
    Berger, Jeffrey S.
    Chen, Yu
    Kornblith, Lucy
    Gong, Michelle
    Cushman, Mary
    Kim, Keri
    Reynolds, Harmony
    Lopes, Renato D., Sr.
    Lopez-Sendon, Jose L.
    Maggioni, Aldo
    Antunes, Murillo de Oliveira
    Atassi, Bassel
    Berry, Scott
    Bochicchio, Grant
    Farkouh, Michael E.
    Greenstein, Yonatan
    Hade, Erinn
    Hudock, Kristin
    Kamel, Hooman
    Khatri, Pooja
    Kirwan, Bridget-Anne
    Kreuziger, Lisa
    Lawler, Patrick R.
    Leifer, Eric
    Maia, Lilia
    McVerry, Bryan J.
    Newman, Jonathan D.
    Wahid, Lana
    Wilson, Jenny Jenny
    Wisniewski, Steve
    Hochman, Judith
    Neal, Matthew D.
    CIRCULATION, 2021, 144 (25) : E573 - E574
  • [2] Aspirin vs P2Y12 Inhibitors A Few Questions Unanswered
    Mostafa, Mostafa Reda
    Abdou, Claudine
    Barssoum, Kirolos
    Jneid, Hani
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (01) : e7 - e7
  • [3] Characteristics of new P2Y12 inhibitors: selection of P2Y12 inhibitors in clinical practice
    Golino, Paolo
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2013, 14 : S22 - S30
  • [4] Aspirin versus P2Y12 inhibitors with anticoagulation therapy for atrial fibrillation
    Fukaya, Hidehira
    Ako, Junya
    Yasuda, Satoshi
    Kaikita, Koichi
    Akao, Masaharu
    Matoba, Tetsuya
    Nakamra, Masato
    Miyauchi, Katsumi
    Hagiwara, Nobuhisa
    Kimura, Kazuo
    Hirayama, Atsushi
    Matsui, Kunihiko
    Ogawa, Hisao
    HEART, 2021, 107 (21) : 1731 - 1738
  • [5] New P2Y12 inhibitors
    Storey, Robert F.
    HEART, 2011, 97 (15) : 1262 - 1267
  • [6] New P2Y12 Inhibitors
    Cattaneo, Marco
    CIRCULATION, 2010, 121 (01) : 171 - 179
  • [7] P2Y12 inhibitors for the neurointerventionalist
    Borchert, Robin J.
    Simonato, Davide
    Hickman, Charlotte
    Fuschi, Maurizio
    Thibault, Lucie
    Henkes, Hans
    Fiorella, David
    Tan, Benjamin Y. Q.
    Yeo, Leonard L. L.
    Makalanda, Hegoda L.
    Wong, Ken
    Bhogal, Pervinder
    INTERVENTIONAL NEURORADIOLOGY, 2022, 28 (01) : 92 - 103
  • [8] Aspirin and P2Y12 Inhibitors in platelet-mediated activation of neutrophils and monocytes
    Schrottmaier, Waltraud C.
    Kral, Julia B.
    Badrnya, Sigrun
    Assinger, Alice
    THROMBOSIS AND HAEMOSTASIS, 2015, 114 (03) : 478 - 489
  • [9] Dose of aspirin does not inluence laboratory antiplatelet efficacy of P2Y12 inhibitors
    Motovska, Z.
    Ondrakova, M.
    Dusek, L.
    Knot, J.
    Ulman, J.
    Bednar, F.
    Widimsky, P.
    EUROPEAN HEART JOURNAL, 2013, 34 : 884 - 884
  • [10] Anticoagulants (thrombin inhibitors) and aspirin synergize with P2Y12 receptor antagonism in thrombosis
    André, P
    LaRocca, T
    Delaney, SM
    Lin, PH
    Vincent, D
    Sinha, U
    Conley, PB
    Phillips, DR
    CIRCULATION, 2003, 108 (21) : 2697 - 2703